First Western Financial, Inc. Announces Completion of $20 Million Subordinated Debt Offering

Written by Customer Service on December 5, 2022. Posted in Public Companies.

DENVER, Dec. 05, 2022 (GLOBE NEWSWIRE) — First Western Financial, Inc. (NASDAQ: MYFW), a financial services holding company headquartered in Denver, Colorado (“First Western” or the “Company”), today announced the issuance and sale (the “Offering”) of $20 million in aggregate principal amount of 7.00% Fixed-to-Floating Rate Subordinated Notes due December 15, 2032 (the “Notes”). The Company intends to use the proceeds from the Offering for general corporate purposes. The Notes are designed to qualify as Tier 2 capital for the Company for regulatory capital purposes and mature on December 15, 2032 (the “Maturity Date”), and bear interest at a fixed annual rate of 7.00%, payable semi-annually in arrears, to, but excluding, December 15, 2027. From and including December 15, 2027 to, but excluding, the Maturity Date or early redemption...

LGI Homes Reports November 2022 Home Closings

Written by Customer Service on December 5, 2022. Posted in Public Companies.

THE WOODLANDS, Texas, Dec. 05, 2022 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 412 homes in November 2022. As of November 30, 2022, the Company had 92 active selling communities. About LGI Homes, Inc. LGI Homes, Inc. is a pioneer in the homebuilding industry, successfully applying an innovative and systematic approach to the design, construction and sale of homes. As one of America’s fastest growing companies, LGI Homes has a notable legacy of more than 19 years of homebuilding excellence, over which time it has closed more than 50,000 homes and has been profitable every year. Headquartered in The Woodlands, Texas, LGI Homes has operations across 35 markets in 20 states and, since 2018, has been ranked as the 10th largest residential builder in the United States based on units closed. Nationally...

Zai Lab Partner Mirati Therapeutics Presents Late-Breaking Results Evaluating Concurrent Adagrasib and Pembrolizumab in First-Line Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Written by Customer Service on December 5, 2022. Posted in Public Companies.

Adagrasib in combination with pembrolizumab demonstrates favorable tolerability and promising preliminary efficacy in patients with first-line advanced/metastatic NSCLC harboring a KRASG12C mutation Findings will be presented on December 7 at the 2022 ESMO Immuno-Oncology Annual Congress, as an oral presentation from 2:05 p.m.-2:15 p.m. CET / 8:05 a.m.-8:15 a.m. ET (Presentation #LBA4) during the “Proffered Paper session 1” session SHANGHAI and CAMBRIDGE, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that the company’s partner Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage oncology company reported preliminary results from the KRYSTAL-7 Phase 2 trial and KRYSTAL-1 Phase 1b cohort...

MediciNova Announces Positive Results from Secondary Analysis of Phase 2 Trial of MN-166 (ibudilast) Published in The American Journal of Drug and Alcohol Abuse

Written by Customer Service on December 5, 2022. Posted in Public Companies.

LA JOLLA, Calif., Dec. 05, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that positive results from a secondary analysis of a Phase 2 trial of MN-166 (ibudilast) in alcohol use disorder (AUD) were published in The American Journal of Drug and Alcohol Abuse. The clinical trial was a collaborative effort between MediciNova and Dr. Lara Ray, Professor, Department of Psychology and Department of Psychiatry and Biobehavioral Sciences, Brain Research Institute at the University of California at Los Angeles (UCLA) and was funded by the National Institute on Drug Abuse (Grant P50 DA005010-33). Topline results from a randomized, double-blind, placebo-controlled Phase 2 trial evaluating...

Delta 9 to Open Thirty-Ninth Cannabis Retail Store

Written by Customer Service on December 5, 2022. Posted in Public Companies.

WINNIPEG, Manitoba, Dec. 05, 2022 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) (“Delta 9” or the “Company”), is pleased to announce the grand opening of its thirty-ninth Delta 9 Cannabis retail store, and seventeenth cannabis store in the Province of Manitoba. Delta 9’s newest retail store is in the heart of the busiest shopping district in Dauphin, Manitoba. “Delta 9 is Manitoba’s Cannabis Store and we’re excited to further expand our retail footprint in rural MB. We will continue to expand our retail portfolio across Canada through organic growth and strategic acquisitions in the coming months,” said John Arbuthnot, CEO of Delta 9. “We started 2020 with four retail stores and now have 39 cannabis retail stores in operation across the Canadian Prairies. The Company has an aggressive growth strategy to...

Saratoga Investment Corp. Prices Public Offering of $52.5 Million 8.125% Notes Due 2027

Written by Customer Service on December 5, 2022. Posted in Public Companies.

NEW YORK, NY , Dec. 05, 2022 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (the “Company”) (NYSE: SAR) today announced that it has priced an underwritten public offering of $52.5 million in aggregate principal amount of 8.125% unsecured notes due 2027 (the “Notes”). The Notes will mature on December 31, 2027, and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after December 13, 2024. The Notes will bear interest at a rate of 8.125% per year payable quarterly on February 28, May 31, August 31, and November 30 of each year, beginning February 28, 2023. The offering is expected to close on December 13, 2022, subject to customary closing conditions. The Company has granted the underwriters an option to purchase up to an additional $7,875,000 in aggregate principal amount of Notes....

Pacifico Acquisition Corp. Stockholders Approve Proposed Merger Transaction with Caravelle

Written by Customer Service on December 5, 2022. Posted in Mergers And Acquisitions.

NEW YORK, Dec. 05, 2022 (GLOBE NEWSWIRE) — Pacifico Acquisition Corp. (Nasdaq: PAFO; “Pacifico”), a publicly traded special purpose acquisition company, today announced that Pacifico’s stockholders voted to approve its proposed business combination with Caravelle Group Co., Ltd (“Caravelle”), an ocean technology company providing international shipping services and a carbon-neutral solution for wood desiccation. At the special meeting of stockholders on November 30, 2022, a total of 6,194,813 ordinary shares, or 82.65% of Pacifico’s issued and outstanding ordinary shares as of October 17, 2022, the record date of the extraordinary general meeting, were present either in person or represented by proxy. Holders of 6,155,465 ordinary shares, or 82.13% of the votes cast at the meeting, voted for the business combination. Pacifico’s...

Diversified Royalty Corp. Announces December 2022 Cash Dividend

Written by Customer Service on December 5, 2022. Posted in Dividend Reports And Estimates.

VANCOUVER, British Columbia, Dec. 05, 2022 (GLOBE NEWSWIRE) — Diversified Royalty Corp. (TSX: DIV; DIV.DB and DIV.DB.A) (the “Corporation” or “DIV”) is pleased to announce that its board of directors has approved a cash dividend of $0.01958 per common share for the period of December 1, 2022 to December 31, 2022, which is equal to $0.235 per common share on an annualized basis. The dividend will be paid on December 30, 2022 to shareholders of record as of the close of business on December 14, 2022. About Diversified Royalty Corp. DIV is a multi-royalty corporation, engaged in the business of acquiring top-line royalties from well-managed multilocation businesses and franchisors in North America. DIV’s objective is to acquire predictable, growing royalty streams from a diverse group of multi-location businesses and franchisors. DIV...

Phillips Edison & Company, Inc. Invites You To Join Its Fourth Quarter 2022 Earnings Conference Call

Written by Customer Service on December 5, 2022. Posted in Public Companies.

CINCINNATI, Dec. 05, 2022 (GLOBE NEWSWIRE) — Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO”), one of the nation’s largest owners and operators of grocery-anchored neighborhood shopping centers, will announce its fourth quarter earnings results on Thursday, February 9, 2023, after the market close. PECO’s earnings release and supplemental information package will be posted on the Investor Relations section of the Company’s website at investors.phillipsedison.com. Chairman and Chief Executive Officer Jeff Edison, President Devin Murphy, and Chief Financial Officer John Caulfield will host an earnings conference call to discuss results, which will be webcast on Friday, February 10, 2023, at 12:00 p.m. ET. Fourth Quarter 2022 Earnings Conference Call Details: Date: Friday, February 10, 2023 Time: 12:00 p.m. ET Toll-Free...

TSX-V approves Warrant Extension

Written by Customer Service on December 5, 2022. Posted in Public Companies.

TORONTO, Dec. 05, 2022 (GLOBE NEWSWIRE) — Unigold Inc. (“Unigold” or the “Company”) (TSX-V:UGD; OTCQX: UGDIF; FSE:UGB1) announces that the TSX-V has approved the extension of the expiry dates of a total of 16,629,167 share purchase warrants (the “Warrants”), by six months to June 23, 2023 (the “Warrant Extension”). The Warrants were issued pursuant to a private placement which closed on June 23, 2020. Each Warrant entitles the holder thereof to acquire one common share of the Company at a price of $0.30 per common share and all other terms of the Warrants, including exercise price, will remain the same. A total of 150,650 Warrants are held by parties who are considered to be “related parties” of the Company. Therefore, the amendment of Warrants constitutes a “related party transaction” as contemplated by Multilateral Instrument...

Day: December 5, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice